Grant: Project Grant

Atrial fibrillation (AF) is a common heart rhythm problem among dialysis patients, which increases their risk of having a stroke. Blood thinners, like apixaban, are often prescribed to prevent strokes in people with AF. This study aims to find out if apixaban can help prevent strokes in dialysis patients with AF compared to not using any blood thinners. In this study, we will look at two groups of dialysis patients with AF. One group will take apixaban, a widely used blood thinner, and the other group will not take any blood thinner. The main goal of the study is to see if taking apixaban helps prevent strokes compared to not using any blood thinners. We will follow the participants for two years, collecting data on strokes, bleeding, and other important outcomes. The results will help doctors make better treatment decisions for dialysis patients with AF, aiming to improve their quality of life and reduce the risks of both strokes and bleeding. Ultimately, this study will help provide more personalized care for this vulnerable group.